Janssen Oncology
Janssen Oncology
See all stories about Janssen Oncology, and learn how Johnson & Johnson's pharmaceutical companies are working to save patients' lives and cure cancer.
Innovation
Could changes in your microbiome increase your risk of colorectal cancer?
That’s exactly what researchers at Johnson & Johnson are trying to find out. By partnering on a new study that’s looking at the role gut microbes may play in the disease—and focusing on the underrepresented groups most affected—they hope to advance early-detection strategies and potential treatments.
Latest news
Johnson & Johnson Named a 2022 Fortune World’s Most Admired Company
Learn how J&J landed on the global corporate reputation list for the 20th year in a row and ranked #1 on the Pharmaceutical Industry list for the ninth consecutive year.
Innovation
“Our goal is to prevent lung cancer from happening in the first place”
Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Healthy Lung Month, Johnson & Johnson researchers share the progress that’s being made to thwart the #1 cancer killer.
Innovation
The next frontier of prostate cancer care
Certain gene mutations can dramatically increase the risk of developing aggressive prostate cancer. That’s why Johnson & Johnson is researching a new way to fight the disease—one that involves blocking cancer cells from repairing their own damaged DNA.
Innovation
Curing cancer from within: The promise of cell therapy
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
Innovation
The quest to help patients with a deadly type of lung cancer
Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. For Lung Cancer Awareness Month, they share their journey.
Innovation
“I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
Health & wellness
5 things we now know about colorectal cancer
Surprising new research suggests that people younger than 50 are getting diagnosed with the disease at record rates. For National Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.
Innovation
From Aha! moment to FDA approval: The fascinating story behind a new treatment for bladder cancer
For National Cancer Prevention Month, we retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of bladder cancer to patients who may benefit most.
Latest news
7 questions for Alex Gorsky about Johnson & Johnson’s groundbreaking work in South Africa
Preventative HIV innovations. Better access to oncology care. A mobile messaging service for moms. These are just a few of the initiatives underway—and Chairman and CEO Alex Gorsky sits down for an exclusive interview about all of them.